Predicting Autism Spectrum Disorder Using Blood-based Gene Expression Signatures and Machine Learning

키워드

참고문헌 (39)

1. Christensen DL, "Prevalence and characteristics of autism spectrum disorder among children aged 8 years--autism and developmental disabilities monitoring network, 11 sites, United States, 2012", MMWR Surveill Summ, 65, pp.1~23 (2016)
2. Warren Z, "A systematic review of early intensive intervention for autism spectrum disorders", Pediatrics, 127, pp.e1303~e1311 (2011)
3. Constantino JN, "Sibling recurrence and the genetic epidemiology of autism", Am J Psychiatry, 167, pp.1349~1356 (2010)
4. Ozonoff S, "Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study", Pediatrics, 128, pp.e488~e495 (2011)
5. Rosenberg RE, "Characteristics and concordance of autism spectrum disorders among 277 twin pairs", Arch Pediatr Adolesc Med, 163, pp.907~914 (2009)
6. Schaefer GB, "Clinical genetics evaluation in identifying the etiology of autism spectrum disorders : 2013 guideline revisions", Genet Med, 15, pp.399~407 (2013)
7. Codina-Solà M, "Integrated analysis of wholeexome sequencing and transcriptome profiling in males with autism spectrum disorders", Mol Autism, 6, pp.21~ (2015)
8. Glatt SJ, "Blood-based gene expression signatures of infants and toddlers with autism", J Am Acad Child Adolesc Psychiatry, 51, pp.934~944.e932 (2012)
9. Hu VW, "Developing a predictive gene classifier for autism spectrum disorders based upon differential gene expression profiles of phenotypic subgroups", N Am J Med Sci (Boston), 6 (2013)
10. Kong SW, "Characteristics and predictive value of blood transcriptome signature in males with autism spectrum disorders", PLoS One, 7, pp.e49475~ (2012)
11. Pramparo T, "Prediction of autism by translation and immune", inflammation coexpressed genes in toddlers from pediatric community practices, 2015, pp.72, 386~394
12. Edgar R, "NCBI GEO standards and services for microarray data", Nat Biotechnol, 24, pp.1471~1472 (2006)
13. Kuwano Y, "Autism-associated gene expression in peripheral leucocytes commonly observed between subjects with autism and healthy women having autistic children", PLoS One, 6, pp.e24723~ (2011)
14. R Core Team, "R: a language and environment for statistical computing" (2013), R Foundation for Statistical Computing
15. Ritchie ME, "limma powers differential expression analyses for RNA-sequencing and microarray studies", Nucleic Acids Res, 43, pp.e47~ (2015)
16. Warnes GR, "gplots : various R programming tools for plotting data", R package version, 2(4), ~ (2012)
17. Cortes C, "Support-vector networks", Mach Learn, 20, pp.273~297 (1995)
18. Shakhnarovich G, "Nearest-neighbor methods in learning and vision: theory and practice" (2006), MIT Press
19. Fisher RA, "The use of multiple measurements in taxonomic problems", Ann Eugen, 7, pp.179~188 (1936)
20. Carey V, "MLInterfaces: uniform interfaces to R machine learning procedures for data in Bioconductor containers", R package version 1.52.0, ~ (2016)
21. Carlson M, "hgug4112a.db: Agilent "Human Genome, Whole"annotation data (chip hgug4112a)", R package version 3.2.2, ~ (2016)
22. Karlovich C, "A longitudinal study of gene expression in healthy individuals", BMC Med Genomics, 2, pp.33~ (2009)
23. Campbell C, "Assessment of normal variability in peripheral blood gene expression", Dis Markers, 18, pp.201~206 (2002)
24. Freeman BJ, "The stability of cognitive and behavioral parameters in autism : a twelve-year prospective study", J Am Acad Child Adolesc Psychiatry, 30, pp.479~482 (1991)
25. Soke GN, "Longitudinal changes in Scores on the Autism Diagnostic Interview--Revised(ADI-R)in pre-school children with autism : Implications for diagnostic classification and symptom stability", Autism, 15, pp.545~562 (2011)
26. Zhu B, "An evaluation of linear RNA amplification in cDNA microarray gene expression analysis", Mol Genet Metab, 87, pp.71~79 (2006)
27. Lee J, "Analysis of blood-based gene expression signature in first-episode psychosis", Psychiatry Res, 200, pp.52~54 (2012)
28. van't Veer LJ, "Gene expression profiling predicts clinical outcome of breast cancer", Nature, 415, pp.530~536 (2002)
29. Purcell AE, "Postmortem brain abnormalities of the glutamate neurotransmitter system in autism", Neurology, 57, pp.1618~1628 (2001)
30. Nagarajan RP, "Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2promoter methylation", Epigenetics, 1, pp.e1~e11 (2006)
31. Campbell DB, "Disruption of cerebral cortex MET signaling in autism spectrum disorder", Ann Neurol, 62, pp.243~250 (2007)
32. Sullivan PF, "Evaluating the comparability of gene expression in blood and brain", Am J Med Genet B Neuropsychiatr Genet, (141B), pp.261~268 (2006)
33. Baron CA, "Utilization of lymphoblastoid cell lines as a system for the molecular modeling of autism", J Autism Dev Disord, 36, pp.973~982 (2006)
34. Rossignol DA, "A review of research trends in physiological abnormalities in autism spectrum disorders:immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures", Mol Psychiatry, 17, pp.389~401 (2012)
35. Herrero Sanchez C, "The DNA-binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters", Mol Cell Biol, 12, pp.4076~4083 (1992)
36. Palmieri L, "Mitochondrial dysfunction in autism spectrum disorders: cause or effect?", Biochim Biophys Acta, 1797, pp.1130~1137 (2010)
37. Gupta V, "Human pyruvate kinase M2 : a multifunctional protein", Protein Sci, 19, pp.2031~2044 (2010)
38. Giulivi C, "Mitochondrial dysfunction in autism", JAMA, 304, pp.2389~2396 (2010)
39. 이연정, "Advanced Pharmacotherapy Evidenced by Pathogenesis of Autism Spectrum Disorder", Clinical Psychopharmacology and Neuroscience, 12(1), pp.19~30 (2014), 대한정신약물학회

관련 논문AI추천